Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma (Q56373211)

From Wikidata
Jump to navigation Jump to search
article by Ghassan K Abou-Alfa et al published 5 July 2018 in The New England Journal of Medicine
edit
Language Label Description Also known as
English
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
article by Ghassan K Abou-Alfa et al published 5 July 2018 in The New England Journal of Medicine

    Statements

    Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma (English)
    0 references
    0 references
    0 references
    Ghassan K Abou-Alfa
    0 references
    Tim Meyer
    0 references
    Ann-Lii Cheng
    0 references
    Anthony B El-Khoueiry
    0 references
    Baek-Yeol Ryoo
    0 references
    Irfan Cicin
    0 references
    Philippe Merle
    0 references
    YenHsun Chen
    0 references
    Joong-Won Park
    0 references
    Jean-Frederic Blanc
    0 references
    Luigi Bolondi
    0 references
    Heinz-Josef Klümpen
    0 references
    Stephen L Chan
    0 references
    Tiziana Pressiani
    0 references
    Min-Hee Ryu
    0 references
    Alan P Venook
    0 references
    Colin Hessel
    0 references
    Anne E Borgman-Hagey
    0 references
    Gisela Schwab
    0 references
    Robin K Kelley
    0 references
    5 July 2018
    0 references
    379
    0 references
    1
    0 references
    54-63
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit